What Skin Toxicities May Signal in Melanoma Patients on Immunotherapy Cutaneous immune-related adverse events (irCAEs) are among the most common side effects seen in patients receiving immune checkpoint inhibitors (ICIs)…
Read More
Painless™ PDT vs. Conventional PDT: A Quick Look at Patient Comfort in AK Treatment Actinic keratosis (AK) is one of the most common conditions treated by dermatologists, and photodynamic therapy…
Read More
Melanoma Education on Instagram: What’s Missing—Especially for Skin of Color As melanoma rates rise, with a projected 7.3% increase in new cases and 3.8% rise in mortality in 2024, the…
Read More
What to Expect When Treating SCC In Situ with Mohs Surgery While squamous cell carcinoma in situ (SCCIS) is typically considered a low-risk skin cancer, treatment decisions, especially around surgical…
Read More
EMPSGC: Why Mohs Might Be the Better Choice Endocrine Mucin Producing Sweat Gland Carcinoma (EMPSGC) is rare, low-grade, and slow-growing—but it’s not without risk. Though uncommon, recurrence and even distant…
Read More
Melanoma Mortality Drops Where Dermatologists Are in High Supply: Read the Data New data shows a powerful link: the more dermatologists in your area, the lower your risk of dying…
Read More
Cylindrocarcinoma: Could Mohs Surgery Be the Clear-Cut Winner? Cylindrocarcinoma—a rare malignant offshoot of benign cylindromas—poses a surgical challenge due to its potential for recurrence and metastasis. While traditional excision has…
Read More
Sonidegib for laBCC: A Neoadjuvant Game Changer? Neoadjuvant Hedgehog Pathway Inhibitors (HPIs) are reshaping the approach to locally advanced basal cell carcinoma (laBCC), but tolerability remains a concern. A recent…
Read More
A Spotlight on Skin Health As February unfolds, so does an important reminder—this month is National Cancer Prevention Month. For dermatologists, it's a time to reinforce awareness, education, and proactive…
Read More
Featured Podcast Cancer has met its match with the rise of new targeted therapies. However with the expanding cancer busting armament comes with the baggage of new and emerging cutaneous…
Read More
JDD Article Highlights Lentigo maligna (LM) and its more invasive form, lentigo maligna melanoma (LMM), are increasingly on dermatologists' radar, especially for elderly patients with sun-damaged skin. Historically, the treatment…
Read More
By Allison Sit The American Academy of Dermatology (AAD) is joining with other specialties in speaking out about cuts to the Medicare Physician Fee Schedule for 2025. The physician services…
Read More
